CURRENT HEADLINES
- Connect Biopharma's Exclusive Licensee In China, Simcere Pharmaceutical, Announced Submission Of Its New Drug Application For Rademikibart For The Treatment Of Atopic Dermatitis In China
- Collaborative Drug Discovery And deepmirror Announce Collaboration For Humanitarian And Commercial Drug Discovery
- KAIST Presents A Breakthrough In Overcoming Drug Resistance In Cancer – Hope For Treating Intractable Diseases Like Diabetes
- Adagene And ConjugateBio Partner To Develop Novel Antibody Drug Conjugate
- New Drug Targets 'Zombie Cells' In Effort To Prevent Liver Disease, Cancer
SUPPLIER NEWS
ARCHIVE NEWSLETTER
- 07.10.25 -- Take a look at our useful PUPSIT overview and implementation resources.
- 07.08.25 -- Designing Our Way Toward Circular RNA Medicines With AI
- 07.01.25 -- Will Genome Modifications Define Next-Gen AAV Vectors?
- 06.24.25 -- Protecting Intellectual Property In The Genomics Revolution
- 06.19.25 -- Your helping hand in filtration for high concentration drugs.
BUSINESS WIRE PRESS
- Eluciderm, Inc. Announces U.S. FDA Clearance Of IND Application For ELU42
- FF-10832 Granted FDA Orphan Drug Designation For The Treatment Of Biliary Tract Cancer
- Quiver Bioscience Secures Non-Dilutive Funding To Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities And Advance Powerful AI/ML-Based In Vitro / In Silico Predictor Of CNS Drug Safety
- Healx And SCI Ventures Join Forces To Uncover Cures For Paralysis With AI-Driven Drug Discovery
- Rocket Pharmaceuticals Announces FDA IND Clearance Of RP-A701 For The Treatment Of BAG3-Associated Dilated Cardiomyopathy
- Enhanced Genomics And The ALBORADA Drug Discovery Institute Partner To Accelerate Alzheimer's Drug Discovery
DOWNLOAD LIBRARY

| Download software |
EVENTS CALENDAR

| Search events |
| Post events |
| Stay informed |
Learn more...
ASSOCIATIONS
Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...